Jinxi plant environmental protection facilities through the completion of acceptance
Release time:
2020-07-30
News from our newspaper 11# April , Jianfeng Pharmaceutical Jinxi Pharmaceutical Factory successfully obtained the approval from Zhejiang Environmental Protection Department that the environmental protection facilities of the project passed the completion acceptance, and a key work of Jianfeng Pharmaceutical 2016 came to an end.
Peak Pharmaceutical Co., Ltd. has an annual output of 35 tons of cephalosporins, antitumor drugs and other raw material production lines and various preparation production lines. The technical renovation project started construction in Jinxi Development Zone in 2012 , 10 , and was basically completed in 2015 , 9 . The construction of the project strictly abides by the "three simultaneous" system of environmental protection, conscientiously implements the requirements in the environmental impact assessment report and its approval documents, and the investment in environmental protection facilities amounts to 1934 yuan. The plant has basically realized the separation of clean and sewage. A new wastewater treatment system with a daily treatment capacity of 700 cubic meters and a "physicochemical biochemical" treatment process has been built, and an online monitoring device connected with the environmental protection department has been installed. All kinds of production wastewater, public works wastewater and domestic sewage will be collected after reaching the standard by the wastewater station and sent to Jinxi Sewage Treatment Plant for centralized treatment; there is a RTO regenerative incineration device with ,000 cubic meters per hour and a ,4,000 cubic meters per hour centralized treatment device for chlorine-containing organic waste gas. All kinds of waste gas are collected and treated and discharged. 2015 10# In July, with the approval of Jinhua Economic and Technological Development Zone Branch of Jinhua Environmental Protection Bureau, Jinxi Project was put into trial production.
2016 7 , Zhejiang Environmental Monitoring Center Station carried out completion acceptance monitoring of environmental protection treatment facilities such as waste water and waste gas in Jinxi Pharmaceutical Factory, and issued a completion acceptance monitoring report of environmental protection facilities at the end of 8 , believing that the completion acceptance conditions of environmental protection facilities for construction projects were basically met. In order to further improve the waste gas treatment work, the pharmaceutical company also commissioned professional institutions to carry out waste gas leakage, detection and repair, and carried out scientific detection on the unorganized emission of VOCs (volatile organic compounds) at each leakage point, repaired the trace leakage point, and finally formed a detection report.
February 13 , relevant departments of Zhejiang provincial environmental protection department presided over an on-site meeting for the completion and acceptance of environmental protection facilities for Jinxi project. The leader of the acceptance team is He Wei, the Construction Project Management Office of the Provincial Environmental Protection Department. The members include leaders of Jinhua Environmental Protection Bureau and other units and provincial environmental protection experts, as well as professional institutions such as Zhejiang Environmental Monitoring Center Station and Zhejiang Huanke Environmental Consulting Co., Ltd. Representative. At the acceptance meeting, Shen Quan, director of Jinxi factory, introduced the main construction contents and operation of environmental protection facilities of Jinxi project. The provincial monitoring station explained the monitoring situation of the project, and Hangzhou Huanliang Environmental Protection Technology Co., Ltd. explained the environmental supervision of the project in detail. The acceptance team also went to the site to inspect the actual operation and use of waste water and waste gas treatment facilities, RTO incineration device, online monitoring system, hazardous waste warehouse, etc., and checked the production status of bulk drug workshop, etc. After careful deliberation, the acceptance team agreed that the project has basically implemented the main environmental protection measures proposed in the EIA and approval, and agreed in principle that the supporting environmental protection facilities have passed the completion acceptance.
1 , Zhejiang Provincial Environmental Protection Department issued an approval document for Jinxi Project to pass the environmental protection completion acceptance, and made requirements for environmental protection precautions after the project is in operation. (Zhu Xiaojing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page